Keith Parent, CEO of Court Square Group and RegDocs365, discusses the importance of vendor management in life science with Kalyan Obalampalli (KO), CEO of ClinAI. KO shares his experience in managing $100 million in vendor contracts and the challenges of using Excel for RFPs and vendor comparisons. He highlights the benefits of ClinAI's platform, which streamlines vendor selection and management, providing analytics and data-driven decision-making. KO emphasizes the need for fit-for-purpose vendor selection, the importance of clear templates, and the potential of AI in predicting costs and ensuring fair vendor payments.

Discover how artificial intelligence is transforming the life sciences industry in this insightful episode of the Driving the Business Science Podcast. Host Keith Parent, CEO of Court Square Group and RegDocs365, is joined by Bryan Reynolds, CEO of Docxonomy, to discuss practical strategies for developing and implementing AI in organizations of all sizes. Drawing on decades of experience in unstructured data management and AI, Bryan shares actionable insights into overcoming common challenges, such as protecting sensitive corporate data, streamlining processes, and maximizing ROI.
This conversation highlights how AI can revolutionize workflows, accelerate drug development timelines, and reduce manual effort in clinical and regulatory environments—all while keeping humans at the center of critical decision-making. Whether you're leading a startup or a large enterprise, this episode provides a roadmap for integrating AI effectively without getting overwhelmed by technical complexity.
Key Topics:
•How life sciences companies can safely adopt AI solutions.
•Practical steps to develop an AI strategy, starting small and scaling.
•Using AI to automate repetitive tasks like document creation and regulatory submissions.
•Ensuring security and maintaining “human in the loop” for oversight.
•The benefits of partnering with AI experts to drive innovation.
What You'll Learn:
•Strategies to safeguard intellectual property while using AI.
•How to identify and optimize manual processes with AI.
•The role of AI in compressing drug development timelines and enhancing efficiency.
•Tips for navigating the complexities of AI adoption in the life sciences sector.
Tune in to gain a fresh perspective on how AI can unlock new opportunities and help your organization thrive in a rapidly evolving industry!

Keith Parent, CEO of Court Square Group, discusses with Kevin Bittorf, a partner at SCxCMC Solutions, about the role of CMC (Chemistry, Manufacturing, and Controls) in the pharmaceutical industry. Kevin explains that CMC involves the science and business of manufacturing, emphasizing the importance of continuous improvement to reduce costs and enhance quality. SCxCMC, founded two years ago, provides consulting services to small and medium-sized companies, integrating expertise in pharmaceutical development, process chemistry, formulation development, regulatory affairs, quality assurance, supply chain, and packaging. Kevin highlights the significance of AI in predicting manufacturing issues and the benefits of continuous manufacturing over traditional batch processes. He also mentions upcoming conferences on compaction simulation, continuous manufacturing, and advancing drug development.